3 Results for "

Cancer-Induced Bone-Pain

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Cancer-Induced Bone-Pain" in MCE Product Catalog:

Cat. No.: HY-W276106
CAS No.: 116850-74-9
Target:  

Others

Research Areas:  

Cancer

KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research .
loading...
    loading...
Cat. No.: HY-153691
CAS No.: 652129-89-0
Target:  

mGluR

Research Areas:  

Others

BTB01303 is a (glutamate release) inhibitor. Cancer cells release high levels of (glutamate), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain .
loading...
    loading...
Cat. No.: HY-132219
CAS No.: 65273-66-7
Purity:  98.22%
Target:  

mGluR

Research Areas:  

Cancer

N. N-dipropyrldopamine is a potent inhibitor of glutamate release and has anticancer activity. The increase of glutamate secretion leads to cancer-induced bone pain (CIBP). N. N-dipropyrldopamine plays an analgesic role in CIBP .
loading...
    loading...